AU3276197A - Drugs for ameliorating renal disorders - Google Patents
Drugs for ameliorating renal disordersInfo
- Publication number
- AU3276197A AU3276197A AU32761/97A AU3276197A AU3276197A AU 3276197 A AU3276197 A AU 3276197A AU 32761/97 A AU32761/97 A AU 32761/97A AU 3276197 A AU3276197 A AU 3276197A AU 3276197 A AU3276197 A AU 3276197A
- Authority
- AU
- Australia
- Prior art keywords
- drugs
- renal disorders
- ameliorating renal
- ameliorating
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8-167286 | 1996-06-27 | ||
JP16728696 | 1996-06-27 | ||
JP8-247635 | 1996-09-19 | ||
JP24763596 | 1996-09-19 | ||
PCT/JP1997/002241 WO1997049427A1 (en) | 1996-06-27 | 1997-06-27 | Drugs for ameliorating renal disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3276197A true AU3276197A (en) | 1998-01-14 |
Family
ID=26491370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU32761/97A Abandoned AU3276197A (en) | 1996-06-27 | 1997-06-27 | Drugs for ameliorating renal disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3276197A (en) |
WO (1) | WO1997049427A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA010687B1 (en) * | 2004-02-06 | 2008-10-30 | Нимокс Корпорейшн | Humanized antibody |
CA2644517A1 (en) * | 2006-03-03 | 2007-09-13 | University Of Southern California | Genetic markers for predicting disease and treatment outcome |
US8512677B2 (en) * | 2009-04-27 | 2013-08-20 | Case Western Reserve University | Pyro-glutamate Aβ targeting agents |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ298145A (en) * | 1994-12-29 | 1998-08-26 | Yamanouchi Pharma Co Ltd | Monoclonal antibodies having inhibitory effect on type ii phospholipase a2, proteins forming part thereof, cells producing them, dna encoding them, recombinant vector comprising the dna and medicament |
-
1997
- 1997-06-27 WO PCT/JP1997/002241 patent/WO1997049427A1/en active Application Filing
- 1997-06-27 AU AU32761/97A patent/AU3276197A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1997049427A1 (en) | 1997-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1750900A (en) | Medication collecting system | |
AU2003204907A1 (en) | A System for Treating Skin Disorders | |
AU6264298A (en) | Hemofiltration system | |
AU1225000A (en) | Combined pharmaceutical estrogen-androgen-progestin | |
GB9602080D0 (en) | Pharmaceutical compounds | |
HUP9901674A3 (en) | New pharmaceutical combination | |
AUPN449295A0 (en) | Radioprotectors | |
AU1566795A (en) | Pharmaceutical ointment base | |
HUP9602745A3 (en) | Anticelladhesive piperidine- und pyrrolidine-carbonacids, pharm | |
AU8495998A (en) | Improved dosage units | |
AU1558899A (en) | Isoquinoline derivatives for use against cns disorders | |
AU1409100A (en) | Drugs | |
AU8591898A (en) | Pharmaceutical compounds | |
GB9609976D0 (en) | Pharmaceutical compounds | |
GB9715490D0 (en) | Pharmaceutical preparation | |
EP0907644A4 (en) | Pharmaceutical preparation | |
AU4330097A (en) | Pharmaceutical compounds | |
GB9621789D0 (en) | Pharmaceutical compounds | |
AU6436998A (en) | Therapeutic uses for antioxidants | |
EP0891775A4 (en) | Remedies for bladder disorders | |
AU4632089A (en) | Therapeutic agent for renal disorders | |
AU1118299A (en) | Pharmaceutical grade garlic | |
AU4169897A (en) | Pharmaceutical compounds | |
AU6117398A (en) | Drugs for ameliorating pulmonary circulation | |
AU3276197A (en) | Drugs for ameliorating renal disorders |